Pharmacokinetics of Two Formulation of Tenofovir Disoproxil Fumarate
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
To evaluate pharmacokinetic profiles of Viproof Film Coated Tablets 300 mg manufactured by
Yung Shin Parm. Ind. Co., Ltd., Taiwan and Viread Tablets manufactured by Patheon, Inc. in
terms of plasma concentrations of tenofovir after a single oral dose of 300 mg tenofovir
disoproxil fumarate in healthy subjects under fasting conditions.